AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2023
May 19, 2023
33148_dirs_2023-05-19_641699bb-7aab-4ef6-b6f4-14a2c66d19c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2023-05-17
Reporting Person: Militello John (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-17 | Common Stock | S | 245 | $21.375 | Disposed | 6116 | Direct |
Footnotes
F1: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.
More from ROCKET PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20